MedTrace Logo

Biomarker Analysis of Gastrointestinal Cancer

NCT01484444 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2011-12-06

No results posted yet for this study

Summary

BIOMARKER ANALYSES

1. FNA Sample:

From each enrolled patient who meets the inclusion criteria, FNA sample will only be taken .

FNA will be carried out only in patients with feasible biopsy or FNA site. Ascites or pleural fluid will be collected for analysis
2. Blood Samples From each enrolled patient who meets the inclusion criteria, blood samples will be collected. 3 mL blood sample will be collected .
3. tumor tissue Archived Tumor Tissue (Slides) Samples Primary tumor and/or a metastatic lesion collected. Approximately 5 unstained slides (if available) are collected.

Conditions

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • won ki kang, MD · Samsung Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2013-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01484444 on ClinicalTrials.gov